CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Related Content
CHA Submits LHHS Appropriations Testimony
CHA submitted witness testimony to the LHHS Appropriations Subcommittees detailing FY27 requests on workforce, mental health, preparedness, research, and safety.
7 Ways Children’s Hospitals Support Youth Mental Health
Children's hospitals have expanded the typical boundaries of hospital care to ensure kids receive essential mental health care at every point in their journey.
Joint Statement on Workplace Violence in Health Care
In health care settings, workplace violence affects nurses, physicians, technicians, pharmacists, support staff, patients, and families alike.